Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
- 31 August 1998
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 77 (5) , 787-795
- https://doi.org/10.1002/(sici)1097-0215(19980831)77:5<787::aid-ijc19>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Dose-rate effects in targeted radiotherapyPhysics in Medicine & Biology, 1996
- Experimental Radioimmunotherapy: Biological Effectiveness and Comparison with External Beam RadiationPublished by Springer Nature ,1996
- Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeabilityInternational Journal of Cancer, 1995
- Dose-rate effects between 0.3 and 30 GY/H in a normal and a malignant human cell lineInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Characterization of second-generation monoclonal antibodies against carcinoembryonic antigenCancer, 1993
- HTO Oral Administration in Mice. I: Threshold Dose Rate for Haematopoietic DeathInternational Journal of Radiation Biology, 1990
- Radiolabeled monoclonal antibodies in the diagnosis and treatment of malignant melanomaSeminars in Nuclear Medicine, 1989
- Dose-rate effect between 1 and 10 Gy/min in mammalian cell cultureThe British Journal of Radiology, 1984
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.Journal of Clinical Investigation, 1983
- GW-39: A NEW HUMAN TUMOR SERIALLY TRANSPLANTABLE IN THE GOLDEN HAMSTERTransplantation, 1966